$RNXT The pivotal Phase III CouGar study will be the second clinical trial evaluating RenovoGem™, a combination drug-device product, in a difficult-to-access solid tumor cancer. Learn more: https://bit.ly/4asSZjH
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.